Zilovertamab vedotin | ROR | Read Reviews & Product Use Citations

Zilovertamab vedotin (VLS-101, MK-2140) is an antibody-drug conjugate (ADC) composed of a humanised monoclonal antibody targeting ROR1 and the anti-mitotic cytotoxic agent monomethyl auristatin E (MMAE). It has potential for the treatment of lymphoid malignancies.

CAS No. 2376463-48-6

Click to purchase products related to Zilovertamab vedotin

Selleck's Zilovertamab vedotin has been cited by 0 Publication

1 Customer Review

Purity & Quality Control

Batch: D401301 Purity: 99% Protein concentration: 5.27mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective ROR Inhibitors

Biological Activity

Description	Zilovertamab vedotin (VLS-101, MK-2140) is an antibody-drug conjugate (ADC) composed of a humanised monoclonal antibody targeting ROR1 and the anti-mitotic cytotoxic agent monomethyl auristatin E (MMAE). It has potential for the treatment of lymphoid malignancies.

References
[1] Kumar A, et al. Am Soc Clin Oncol Educ Book. 2022;42:1-15.

References

[1] Kumar A, et al. Am Soc Clin Oncol Educ Book. 2022;42:1-15.

Product Details

CAS No.	2376463-48-6
ADC antiody	Zilovertamab
ADC cytotoxin	MMAE
Formulation	1xPBS
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field